These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20827226)

  • 1. EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.
    Kane AJ; Sughrue ME; Rutkowski MJ; Phillips JJ; Parsa AT
    Neuroreport; 2010 Nov; 21(16):1018-22. PubMed ID: 20827226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.
    Rutkowski MJ; Sughrue ME; Kane AJ; Kim JM; Bloch O; Parsa AT
    J Neurooncol; 2011 Nov; 105(2):165-71. PubMed ID: 21503828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
    Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
    PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets.
    Hoelzinger DB; Mariani L; Weis J; Woyke T; Berens TJ; McDonough WS; Sloan A; Coons SW; Berens ME
    Neoplasia; 2005 Jan; 7(1):7-16. PubMed ID: 15720813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
    Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
    Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.
    Chigurupati S; Venkataraman R; Barrera D; Naganathan A; Madan M; Paul L; Pattisapu JV; Kyriazis GA; Sugaya K; Bushnev S; Lathia JD; Rich JN; Chan SL
    Cancer Res; 2010 Jan; 70(1):418-27. PubMed ID: 20028870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
    Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
    PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT6 expression in glioblastoma promotes invasive growth.
    Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
    BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
    Sun J; Zhao B; Du K; Liu P
    Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. circFLNA promotes glioblastoma proliferation and invasion by negatively regulating miR‑199‑3p expression.
    Sun Y; Ma G; Xiang H; Wang X; Wang H; Zhang Y; Qie F; Li C
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34498720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
    Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
    BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-429 Inhibits Astrocytoma Proliferation and Invasion by Targeting BMI1.
    Peng G; Liao Y; Shen C
    Pathol Oncol Res; 2017 Apr; 23(2):369-376. PubMed ID: 27663885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
    Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.
    Liu B; Liu Y; Jiang Y
    Oncol Rep; 2015 May; 33(5):2583-91. PubMed ID: 25708368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.